Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2021-07-28 00:00:00 ET · period of report 2021-07-26 · accession 0001209191-21-048437 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-28 | 2021-07-26+ | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +12.9K | 456.1K | +3% | +$26.8K |
| DM | 2021-07-28 | 2021-07-26+ | KYMR | Mainolfi Nello | CEO, Dir | S - Sale+OE | $60.15 | -12.9K | 452.2K | -3% | -$774.7K |
| DM | 2021-07-28 | 2021-07-26+ | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $0.00 | -12.9K | 117.7K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-26 | M | A | 9,015 | $2.08 | 461,214 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-28 | S | D | 3,864 | $60.15 | 452,199 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2021-07-28 | M | A | 3,864 | $2.08 | 456,063 | D | — | — | |
| 4 | Common | Common Stock | 2021-07-26 | S | D | 9,015 | $60.15 | 452,199 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-07-28 | M | D | 3,864 | $0.00 | 113,846 | D | $2.08 · — to 2029-11-13 | 3,864 Common Stock | (F3) The shares underlying this stock option shall vest upon the achievement of specified performance-based milestones. |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-07-26 | M | D | 9,015 | $0.00 | 117,710 | D | $2.08 · — to 2029-11-13 | 9,015 Common Stock | (F3) The shares underlying this stock option shall vest upon the achievement of specified performance-based milestones. |